This page has moved. Click here to view.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical Library. Full Text Journals Medical Books Online. Physicians Drug Reference

Color Atlas of Skin Diseases

C *CA 19-9 -- Cancer -- Cancrum oris (noma) -- Capnocytophaga ochracea Capnocytophaga sputigena -- Carcinoma(s) Carcinoma -- Cardiac output Cardiac performance, control of -- Cardinal manifestations and presentation of disease Cardiobacterium hominis -- Cardiovascular disease Cardiovascular system -- Cefuroxime -- Celiac catheterization, for pancreatic disease -- Central nervous system -- Central venous access, for parenteral nutrition -- Cervical spondylosis Cervicitis, mucopurulent (MPC) -- Chemoprevention, of cancer Chemoreceptor trigger zone -- Chemotherapy Chenodeoxycholate (CDCA) -- Chlamydial infections Chlamydia pneumoniae -- Chloroquine Chlorothiazide, for heart failure -- Cholera (Vibrio cholerae) Cholera vaccine -- Chromatin Chromium -- Cidofovir Cigar smoking -- Cirrhosis Cisapride -- Clonidine Cloning -- Coagulation disorders Coagulation factor(s) -- Cognitive dysfunction Cognitive evoked potentials -- Colon cancer Colonic diverticula -- Complement pathway Complement system -- Congenital heart disease Congenital muscular dystrophy -- Copolymer I (COP-I), for multiple sclerosis Copper -- Cortisol Cortisol-binding globulin (CGB; transcortin) -- Cranial nerves Cranial neuralgias -- Cryptococcosis (Cryptococcus neoformans) Cryptogenic fibrosing alveolitis -- Cyanosis Cyclic AMP response element binding (CREB) -- Cystic fibrosis Cystic teratomas, and chronic anovulation -- Cytomegalovirus (CMV) Cytosine arabinoside -- Cytotoxins

 

CA 19-9 [ch81 Table3]

and pancreatic cancer

CA 125 [ch81 Table3] [ch99 8] [ch99 10] [ch99 21] [ch101 9]

for ovarian cancer [ch82 50]

Cachectin

 

[see: Tumor necrosis factor ]

Cache Valley virus [ch200 23]

Cachexia

in cancer [ch81 41]

in heart failure [ch233 44]

Cacosmia [ch28 8]

Cadherins, and cancer invasion [ch85 11-12]

Cadmium poisoning [ch397 37-41]

clinical toxicology [ch397 39]

laboratory findings [ch397 40]

and lung disease [ch254 Table1]

metabolism [ch397 38]

source [ch397 37]

treatment [ch397rx4]

Café au lait spots [ch57 40] [ch375 57]

Calabar swellings [ch223 34]

Calciferol [ch353 49]

 

[see also: Vitamin D]

Calcific tendinitis [ch326 75]

Calcinosis

cutis [ch57 68]

metastatic [ch57 68]

tumor [ch353 26]

Calcitonin [ch353 77-84]

catecholamines and [ch70 49]

for hypercalcemia [ch102 12] [ch354 127]

measurement, in diarrhea [ch42 52]

for osteoporosis [ch355 33]

for Paget's disease [ch358 15-16]

as tumor marker [ch81 Table3]

Calcitriol [ch353 49]

for rickets/osteomalacia [ch355 66]

Calcium

absorption [ch285 24] [ch285 Table2]

and cardiac activation [ch232 Figure4] [ch232 8-9]

deficiency

 

[see also: Hypocalcemia]

pathophysiology [ch353 19-20]

dietary intake [ch353 14]

disorders [ch354]

in pregnancy [ch7 37]

endogenous fecal [ch353 15]

excess

 

[see also: Hypercalcemia]

pathophysiology [ch353 19-20]

excretion [ch353 15-16]

G protein and [ch83 26]

and heart failure [ch232 57]

and hypertension [ch246 12]

idiopathic lithiasis [ch279 31]

in illness [ch73 Table1]

malabsorption test [ch285 35]

metabolism [ch353 Figure2] [ch353 11-20]

for osteoporosis [ch355 31-32] [ch355 Table2]

recommended dietary allowance (RDA) [ch72 Table1]

regenerative release [ch232 8]

in renal failure, chronic (CRF) [ch271 Figure2] [ch271 5] [ch271 20-24]

Calcium carbonate, for duodenal ulcers [ch284 64]

Calcium channel, disorders of muscle [ch383 128-132]

Calcium channel blockers

antiarrhythmic dosages [ch231 Table5]

antiarrhythmic effects of [ch231 Table2]

and continence [ch9 Table4]

for diarrhea [ch42 54]

for hypertension [ch246 71] [ch246 72]

dosages and side effects [ch246 Table4]

for myocardial infarction [ch243 65]

for myocardial ischemia [ch244 57] [ch244 59] [ch244 Table1]

poisoning/overdosage [ch391 85-89]

diagnosis [ch391 88]

toxicity [ch391 87]

treatment [ch391rx9]

for pulmonary hypertension [ch260 19]

for Raynaud's phenomenon [ch248 52] [ch314 44]

Calcium hydroxyapatite (HA) deposition disease [ch323 1] [ch323 9-14]

clinical manifestations [ch323 11]

diagnosis [ch323 Figure2] [ch323 12-13]

pathogenesis [ch323 9-10] [ch323 Table2]

treatment [ch323 14]

Calcium infusion test, in Zollinger-Ellison syndrome [ch284 175]

Calcium oxalate (CaOx) deposition disease [ch323 1] [ch323 15-19] [ch349 50-55]

clinical manifestations [ch323 Figure3] [ch323 17-18]

hyperoxaluria of [ch349 50-55]

pathogenesis [ch323 15-16]

treatment [ch323 19]

Calcium pyrophosphate dihydrate (CPPD) disease [ch323 1] [ch323 2-8]

clinical manifestations [ch323 Figure1] [ch323 4-7]

pathogenesis [ch323 2-3] [ch323 Table1] [ch323 Table2]

treatment [ch323rx1]

Calcium stones [ch268 24]

renal [ch279 1-2] [ch279 Table1]

 

[see also: Nephrolithiasis]

distal renal tubular acidosis [ch279 26]

hyperoxaluria [ch279 27-28]

treatment [ch279rx3]

hyperuricosuria [ch279 25]

hypocitrauria [ch279 29-30]

treatment [ch279rx4]

idiopathic calcium lithiasis [ch279 31]

idiopathic hypercalciuria [ch279 22]

treatment [ch279rx2]

Calculi (stones)

biliary

 

[see: Choledocholithiasis]

gallbladder

 

[see: Gallstones]

periodontal [ch31 7]

renal

 

[see: Nephrolithiasis]

urinary bladder

Crohn's disease and [ch286 32]

and Paget's disease [ch358 9]

and voiding dysfunction [ch48 8]

Caliciviridae [ch182 Figure1] [ch182 Table1]

Caliciviruses [ch194 13-19]

clinical immunity [ch194 18]

diagnosis, treatment, and prevention [ch194 19]

epidemiology [ch194 14]

manifestations [ch194 17]

pathophysiology [ch194 16]

California virus encephalitis [ch200 44-48] [ch379 40] [ch379 Table6]

Caloric restriction

aging and [ch9 6]

for hypertension [ch246 55]

Calovo virus [ch200 23]

Calymmatobacterium granulomatosis [ch166]

 

[see also: Donovanosis]

Camptothecin, for cancer [ch86 66]

Campylobacter [ch160]

arthritis [ch324 35]

clinical manifestations [ch160 9-10]

complications [ch160 11-13]

defined [ch160 1]

diarrhea [ch42 17] [ch128 24]

differential diagnosis [ch160 15]

epidemiology [ch160 3-5]

and HIV disease [ch160 4] [ch160 12] [ch308 176] [ch308 178] [ch308 234]

travel and [ch123 31]

laboratory findings [ch160 14]

microbiology [ch160 2]

logy [ch160 6-8]

polyneuropathy [ch381 36]

prognosis [ch160 18]

treatment [ch160rx1]

Campylobacter coli [ch160 2] [ch160 Table1]

Campylobacter fetus [ch160 2] [ch160 Table1]

clinical manifestations [ch160 9-10]

Campylobacter hyointestinalis [ch160 Table1]

Campylobacter jejuni [ch160]

 

[see also: Campylobacter]

differential diagnosis [ch286 44]

and GI bleeding [ch44 18]

Campylobacter lari [ch160 2] [ch160 Table1]

Campylobacter sputorum [ch160 Table1]

Campylobacter upsaliensis [ch160 2] [ch160 Table1]

Camurati-Engelman disease [ch359 16]

Cancer

 

[see also: Neoplasia and individual organ tumors]

adrenal insufficiency and [ch104 52]

airway obstruction and [ch104 39]

approach to the patient [ch81]

Ball's disease and [ch104 37]

biliary obstruction and [ch104 18-19]

breast [ch91]

cachexia in [ch81 41]

cardiac [ch241 1-14]

cell biology [ch83]

C protein-linked receptors [ch83 23-27] [ch83 Table2]

cytoskeleton and cell adhesion [ch83 39-42]

enzyme-linked receptors [ch83 Figure3] [ch83 Figure4] [ch83 28-38]

principles of cell cycle regulation [ch83 Figure1] [ch83 Figure2] [ch83 7-16] [ch83 Table1]

regulation of cell death [ch83 43-46]

regulation of gene transcription [ch83 47-50]

signaling from outside cell to the nucleus [ch83 17-38]

chemotherapy

 

[see: Chemotherapy]

chromosomal translocations [ch81 6] [ch84 Table4]

clinical staging [ch81 10]

clonal nature of [ch84 1]

clostridial sepsis and [ch148 33]

complications

long-term [ch81 25-27]

treatment [ch81 19-24]

defined [ch83 1]

defining extent of disease [ch81 9-15]

diagnosis [ch81 6-8]

effusions from [ch81 37-40]

emergencies [ch104]

in acute promyelocytic leukemia treatment [ch104 75]

adrenal insufficiency [ch104 52]

airway obstruction [ch104 39]

Ball's disease [ch104 37]

hemolytic-uremic syndrome [ch104 60-64]

hemoptysis [ch104 38]

hemorrhagic cystitis [ch104 74]

hypercalcemia [ch104 40-45]

hypoglycemia [ch104 51]

increased intracranial pressure [ch104 31-34]

intestinal obstruction [ch104 12-14]

lactic acidosis [ch104 50]

malignant biliary obstruction [ch104 18-19]

metabolic [ch104 40-53]

neutropenia and infection [ch104 65]

pericardial effusion/tamponade [ch104 9-11]

pulmonary infiltrates [ch104 66-72]

seizures [ch104 35-36]

SIADH [ch104 46-49]

spinal cord compression [ch104 20-29]

structural-obstructive [ch104 2-39]

superior vena cava syndrome [ch104 2-8]

treatment-related [ch104 54-76]

tumor-lysis syndrome [ch104 54-59]

typhlitis [ch104 73]

urinary obstruction [ch104 15-17]

end-of-life decisions [ch81 50]

epidemiology [ch81 2]

Epstein-Barr virus and [ch186 20-21]

familial predisposition to [ch81 5]

fever and [ch125 10] [ch125 Table3]

gastrointestinal tract [ch92]

endocrine tumors [ch95]

genetics [ch84]

acquired mutations [ch84 Figure6] [ch84 21-22] [ch84 Table3]

chromosomal alterations [ch84 Figure11] [ch84 30-34] [ch84 Table4]

classes of cancer genes [ch84 6-8]

complex inherited forms [ch84 Figure5] [ch84 15-18]

DNA amplification [ch84 Figure9] [ch84 Figure10] [ch84 27-29]

epigenetic regulation of gene expression [ch84 35-36]

future research [ch84 37-39]

mechanisms of somatic mutation of oncogenes [ch84 25-34]

Mendelian syndromes [ch84 Figure1] [ch84 Figure2] [ch84 Figure3] [ch84 Figure4] [ch84 9-14] [ch84 Table1] [ch84 Table2]

multistep basis of cancer [ch84 Figure7] [ch84 Figure8] [ch84 23]

point mutation [ch84 26]

RNA and DNA tumor viruses [ch84 4]

testing and counseling [ch84 19]

glomerular disease and [ch275 63-64]

gynecologic [ch99]

head and neck [ch89]

hemolytic-uremic syndrome and [ch104 60-64]

hemoptysis and [ch104 38]

hemorrhagic cystitis and [ch104 74]

hepatobiliary tract [ch93]

hypercalcemia and [ch104 40-45]

hypoglycemia and [ch104 51]

incidence [ch81 Figure1]

increased intracranial pressure and [ch104 31-34]

infections and [ch87]

abnormalities that predispose to [ch87 38-40]

antibacterial therapy for [ch87 41-47]

antibiotic prophylaxis [ch87 56]

antifungal therapy for [ch87 48-49]

brain abscess [ch87 24]

cardiovascular [ch87 33]

catheter-related [ch87 13-14]

central nervous system-specific syndromes [ch87 22-24]

Clostridium difficile diarrhea [ch87 21]

encephalitis [ch87 23]

endocrine syndromes [ch87 34]

gastrointestinal tract-specific syndromes [ch87 15-21]

granulocyte transfusions for [ch87 50-52]

hematopoietic disorders and [ch87 39-40]

lower GI [ch87 19]

lymphoid disorders and [ch87 38]

musculoskeletal [ch87 35]

predisposition [ch87 2] [ch87 Table1]

prevention [ch87 53-58]

pulmonary [ch87 25-32] [ch87 Table5]

renal and ureteral [ch87 36-37]

skin-specific syndromes [ch87 7-12]

splenectomy and [ch87 4] [ch87 Table2]

treatment [ch87 41-52]

typhlitis [ch87 20]

upper GI [ch87 15-18]

vaccination and [ch87 57-58]

intestinal obstruction and [ch104 12-14]

invasion [ch85]

Karnofsky performance index [ch81 Table2]

lactic acidosis and [ch104 50]

liver and biliary tract [ch93]

lung [ch90]

lymphoid cell malignancies [ch113]

management [ch81 19-24]

metabolic emergencies [ch104 40-53]

metastatic [ch85]

 

[see also: Metastases]

sites [ch81 11] [ch85 Table1]

of unknown primary site [ch101]

mortality rates [ch81 Figure1] [ch81 Figure2] [ch81 4]

nausea in [ch81 33-36]

neoadjuvant therapy [ch81 16]

neutropenia and infection in [ch104 65]

nutritional care [ch81 41-43]

pain in [ch81 29-32]

pancreas [ch94]

endocrine tumors [ch95]

pathologic staging [ch81 10]

patient management [ch81 5-51]

pericardial effusion/tamponade and [ch104 9-11]

pericarditis and [ch240 30] [ch240 36]

prevention and early detection [ch82]

prognosis [ch81 9-15]

prostate [ch97]

psychosocial care [ch81 44-45]

pulmonary infiltrates and [ch104 66-72]

radiation therapy for [ch81 16]

recurrence rates [ch81 26]

renal and urinary tract [ch96]

renal parenchymal disease and [ch276 26-28]

in renal transplantation [ch272 58]

risk factors for [ch81 3]

sarcomas [ch100]

seizures and [ch104 35-36]

SIADH and [ch104 46-49]

skin [ch88]

spinal cord compression and [ch104 20-29]

staging [ch81 10-12]

TNM [ch81 12]

structural-obstructive emergencies [ch104 2-39]

superior vena cava syndrome and [ch104 2-8]

supportive care [ch81 28-51]

death and dying [ch81 47-49]

for effusions [ch81 37-40]

end-of-life decisions [ch81 50]

for nausea [ch81 33-36]

nutritional [ch81 41-43]

for pain [ch81 29-32]

psychosocial [ch81 44-45]

surgical therapy for [ch81 16]

testicular [ch98]

treatment [ch86]

complications [ch81 19-24]

of infections [ch87 41-52]

long-term follow-up [ch81 25-27]

plans [ch81 16]

treatment-related emergencies [ch104 54-76]

tumor burden [ch81 12]

tumor-lysis syndrome and [ch104 54-59]

tumor markers [ch81 22] [ch81 Table3]

typhlitis and [ch104 73]

of unknown primary site (CUPS) [ch101]

 

[see also: Metastases, of unknown primary site]

urinary obstruction and [ch104 15-17]

viral infections and [ch182 32]

 

C *CA 19-9 -- Cancer -- Cancrum oris (noma) -- Capnocytophaga ochracea Capnocytophaga sputigena -- Carcinoma(s) Carcinoma -- Cardiac output Cardiac performance, control of -- Cardinal manifestations and presentation of disease Cardiobacterium hominis -- Cardiovascular disease Cardiovascular system -- Cefuroxime -- Celiac catheterization, for pancreatic disease -- Central nervous system -- Central venous access, for parenteral nutrition -- Cervical spondylosis Cervicitis, mucopurulent (MPC) -- Chemoprevention, of cancer Chemoreceptor trigger zone -- Chemotherapy Chenodeoxycholate (CDCA) -- Chlamydial infections Chlamydia pneumoniae -- Chloroquine Chlorothiazide, for heart failure -- Cholera (Vibrio cholerae) Cholera vaccine -- Chromatin Chromium -- Cidofovir Cigar smoking -- Cirrhosis Cisapride -- Clonidine Cloning -- Coagulation disorders Coagulation factor(s) -- Cognitive dysfunction Cognitive evoked potentials -- Colon cancer Colonic diverticula -- Complement pathway Complement system -- Congenital heart disease Congenital muscular dystrophy -- Copolymer I (COP-I), for multiple sclerosis Copper -- Cortisol Cortisol-binding globulin (CGB; transcortin) -- Cranial nerves Cranial neuralgias -- Cryptococcosis (Cryptococcus neoformans) Cryptogenic fibrosing alveolitis -- Cyanosis Cyclic AMP response element binding (CREB) -- Cystic fibrosis Cystic teratomas, and chronic anovulation -- Cytomegalovirus (CMV) Cytosine arabinoside -- Cytotoxins

 

 

C-1 Esterase Deficiency

C-11 Hydroxylase Deficiency

Cachexia

Cadmium Poisoning

Calcinosis Cutis

Campylobacter Infections

Candidiasis (Mucosal)

Candidiasis

Cannabis Compound Abuse

Caprine Arthritis Encephalitis Virus

Carcinoid Tumor, Pancreatic

Carcinoid Tumor, Intestinal

Carcinoma of the Ampulla of Vater

Cardiac Neoplasms, Primary

Cardiac Sarcoma

Cardiac Rhabdomyoma

Cardiac Lipoma

Cardiac Amyloidosis

Cardiac Tamponade

Cardiac Hemangioma

Cardiac Fibroma

Cardiac Death, Sudden

Cardiac Cirrhosis

Cardiac Arrest

Cardiobacterium

Cardiogenic Shock

Cardiomyopathy, Diabetic

Cardiomyopathy, Hypertrophic

Cardiovascular Collapse

Carotid Sinus Hypersensitivity

Cat Scratch Disease

Caustic Ingestion

Cavernous Hemangioma

Celiac Sprue

Cellulitis

Cervical Cancer

Cervicitis

Cestode Diseases

Chagas Disease (American Trypanosomiasis)

Chancroid

Charcot-Leyden Crystal

Cheese Washer's Lung

Cheilitis Granulomatosa (Miescher-Melkersson-Rosenthal Syndrome)

Chemical Worker's Lung

Cherry Hemangioma

Chest Pain

Chickenpox

Chiggers

Chikungunya Viral Arthritis

CHILD Syndrome

Chlamydia Pneumonia

Chlamydial Genitourinary Infections

Chlorphenesin Poisoning

Choanal Atresia

Cholangiocarcinoma

Cholangiohepatitis

Cholangiosarcoma

Cholangitis

Cholecystitis

Cholecystopathy, Acalculous

Cholecystosis, Hypertrophic

Choledochal Cysts

Choledocholithiasis

Cholelithiasis

Cholera

Cholestasis

Cholesteatoma

Cholesterol Granuloma

Cholesterolosis

Chondrodermatitis Nodularis Helicis

Chondromas of Skin and Soft Tissue

Choriocarcinoma, Testicular

Christmas Disease (Hemophilia Type B)

Chromoblastomycosis

Chronic Mesenteric Ischemia

Chronic Gastric Ulcer

Chronic Active Hepatitis

Chronic Bronchitis

Chronic Obstructive Pulmonary Disease

Chronic Myelogenous Leukemia

Chronic Myelomonocytic Leukemia

Chronic Lymphocytic Leukemia

Chronic Renal Failure

Chronic Fatigue Syndrome

Chronic Venous Insufficiency

Churg-Strauss Syndrome (Allergic Granulomatosis)

Churilov's Disease (Hemorrhagic Fever)

Chyle Fistula

Chylothorax

Chylous Ascites

Cicatricial Pemphigoid

Cirrhosis, Postviral

Cirrhosis, Cryptogenic

Clostridial Cholecystitis

Clostridial Necrotizing Fasciitis

Clostridial Gas Gangrene

Clostridium Difficile Colitis

CMV Esophagitis

CMV Retinitis

CMV Colitis

CMV Hepatitis

CMV Pneumonia

Coal Worker's Pneumoconiosis

Cocaine Abuse and Poisoning

Coccidioidomycosis

Coffee Worker's Lung

Cold Agglutinin Immune Hemolysis

Cold Hemoglobinuria, Paroxysmal

Cold Agglutinin Disease

Colloid Milium

Colon Cancer, Adenocarcinoma

Colonic Polyps

Colonic Obstruction

Colorado Tick Fever

Complement Deficiencies

Complement Component 1 Inhibitor Deficiency

Complex IV Deficiency

Complex II Deficiency

Complications of Dermatologic Laser Surgery

Compost Lung

Cone Shell Poisoning

Confluent and Reticulated Papillomatosis

Congenitally Corrected Transposition

Conn's Syndrome

Connective Tissue Nevus

Constipation

Contact Dermatitis (Irritant)

Contact Dermatitis (Allergic)

Cooley's Anemia

Coproporphyria, Hereditary

Cor Pulmonale

Cor Triatriatum

Coral Wounds and Stings

Coronary Artery Vasospasm

Coronary Artery Atherosclerosis

Coronary Artery Anomalies

Coronaviruses

Corpus Luteum Rupture

Corrosive Gastritis

Corynebacterium Infections

Cowden's Disease (Multiple Hamartoma Syndrome)

Cowpox

Cowpox Infection (Human)

Coxsackieviruses

Crabs

Crest Syndrome

Cretinism

Crigler-Nijjar Syndrome

Crohn's Disease

Cryoglobulinemia

Cryoimmunoglobulinemia, Essential Mixed

Cryptochordism

Cryptococcosis

Cryptosporidiosis

Cushing's Syndrome

Cushing's Ulcer

Cutaneous Horn

Cutaneous Laser Resurfacing

Cutaneous Larva Migrans

Cutaneous Larva Migrans

Cutaneous CD30+ (Ki-1) Anaplastic Large-Cell Lymphoma

Cutaneous T Cell Lymphoma

Cutaneous Horn

Cutaneous Laser Resurfacing

Cutaneous T Cell Lymphoma

Cutaneous Larva Migrans

Cutaneous Laser Resurfacing

Cutaneous CD30+ (Ki-1) Anaplastic Large-Cell Lymphoma

Cutaneous T Cell Lymphoma

Cutis Laxa (Elastolysis)

Cyanide Poisoning

Cyanosis

Cyclobenzaprine Poisoning

Cyclooxygenase Deficiency

Cylindroma

Cystadenomas, Hepatic

Cystathioninuria

Cystic Fibrosis

Cysticercosis

Cystinosis

Cystinuria

Cystitis

Cystosarcoma Phyllodes

Cytochrome B5 Reductase Deficiency

Cytochrome P-450 Deficiency

Cytochrome C Oxidase Deficiency

Cytomegalovirus